The investment from Development Partners International (DPI) represents the close of the largest healthcare deal of its kind in Egypt
Alameda Healthcare is Egypt’s leading private healthcare group; the new investment will fuel its local and regional expansion, including into the Gulf Cooperation Council (GCC)
DPI and its partners will work closely with Alameda Healthcare’s leadership team and Dr. Fahad Khater, Chairman, who remains the majority shareholder
London and Cairo, 19th February 2026 – Development Partners International (“DPI”) today announced the completion of their $190 million investment in Alameda Healthcare, Egypt’s leading private healthcare group.
This investment, which is primarily a capital raise, marks the largest healthcare investment of its kind in Egypt to date. The new funding and DPI’s partnership is set to fuel Alameda Healthcare’s strategic expansion within Egypt and across the Gulf Cooperation Council (GCC) region and Africa.
Since DPI signed the agreement in July 2025, Alameda has continued to execute on its growth strategy by expanding its footprint in sub-Saharan Africa with a clinic in Kenya. The group is also seeing significant growth in the number of international patients travelling from across the region to access high-quality specialist care at Alameda’s Joint Commission International (JCI) accredited hospitals.
Alameda is actively pursuing further opportunities for growth across the region, including international partnerships which enhance care and optionality for patients. In January, Alameda announced a multi-year strategic partnership with Houston Methodist which focuses on advancing high-quality, patient-centered care at the Madinaty Hospital in New Cairo, Egypt.
DPI will collaborate closely with Alameda Healthcare’s executive team led by Chairman Dr. Fahad Khater, who retains his position as the majority shareholder.
To read the initial announcement of the transaction, go to DPI’s website: Development Partners International.
Ziad Abaza, Partner at Development Partners International said: “We are pleased to finalise this milestone transaction and look forward to our partnership with Dr. Fahad Khater and his team in delivering world-class healthcare across Egypt and the GCC.”
Dr. Fahad Khater, Chairman of Alameda Healthcare, said: “With DPI’s support we have already begun to execute on our growth strategy and our partnership with Houston Methodist is a testament to that. DPI’s support and deep regional networks will help us treat more patients and will expand access to high-quality healthcare across Egypt, especially in underserved areas. We look forward to launching into our next phase of growth across the KSA, UAE, and the wider GCC markets.”
EFG Hermes acted as the Sole M&A Financial Advisor on the Transaction. Addleshaw Goddard LLP acted as international legal counsel, while ALC Alieldean Weshahi & Partners and Matouk Bassiouny & Hennawy as local legal counsels to Alameda Healthcare. White & Case LLP acted as international and local legal counsel to DPI. PricewaterhouseCoopers (PwC), Debevoise & Plimpton LLP and Rothschild & Co. were also members of DPI’s consortium of advisors.